Favourable response to plasma exchange in tumefactive CNS demyelination with delayed B-cell response

Abstract

We report a case of multiple sclerosis-associated fulminant tumefactive demyelinating lesion (TDL) with the special feature of delayed humoral immune response. Plasma exchange (PE) yielded significant benefit in two consecutive steroid-unresponsive relapses, while signs of an intrathecal B-cell response were only present 2 years later at the second relapse. Remission was achieved and sustained thereafter with natalizumab. Our case indicates that PE might be a therapeutic option even when the B-cell response is not fully developed. This delay in the development of a humoral immune response may reflect the step-wise B-cell colonization of the CNS and represent an attractive therapeutic window of opportunity.

Keywords

humoral immune response immunopathogenesis multiple sclerosis plasma exchange treatment tumefactive demyelination

Get full access to this article

View all access options for this article.

References

Xia

Lin

Wang

. Tumefactive demyelinating lesions: nine cases and a review of the literature. Neurosurg Rev 2009; 32: 171–179.

Kepes

. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 1993; 33: 18–27.

Lucchinetti

Brück

Parisi

Scheithauer

Rodriguez

Lassmann

. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 1999; 122: 2279–2295.

Cepok

Rosche

Grummel

. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005; 128: 1667–1676.

Zhou

Srivastava

Nessler

. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci U S A 2006; 103: 19057–19062.

Keegan

König

McClelland

. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 2005; 366: 579–582.

Magaña

Keegan

Weinshenker

. Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol 2011; 68: 870–878.

Lovato

Willis

Rodig

. Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain 2011; 134: 534–541.

Stüve

Marra

Jerome

. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol 2006; 59: 743–747.

10.